Mary Leuchars

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 18

Top Topics

Combination Therapy

Induced Pluripotent Stem Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature (2024)
Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, Stephanie Grunewald
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature 628 (8009) (2024)